Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Muzafar A Macha

Showing results (11-20 of 81) with videos related to

Pageof 9
Sort By:
International Journal of Cancer|January 15, 2009
Cytoplasmic accumulation of activated leukocyte cell adhesion molecule is a predictor of disease progression and reduced survival in oral cancer patientsMeenakshi Sawhney, Ajay Matta, Muzafar A Macha, et al.
Advanced Drug Delivery Reviews|December 3, 2014
Clinical implications of miRNAs in the pathogenesis, diagnosis and therapy of pancreatic cancerSatyanarayana Rachagani, Muzafar A Macha, Nicholas Heimann, et al.
Carcinogenesis|November 27, 2018
Novel therapies hijack the blood-brain barrier to eradicate glioblastoma cancer stem cellsRaghupathy Vengoji, Moorthy P Ponnusamy, Satyanarayana Rachagani, et al.
Current Pharmaceutical Design|February 1, 2014
MicroRNAs (miRNAs) as biomarker(s) for prognosis and diagnosis of gastrointestinal (GI) cancersMuzafar A Macha, Parthasarathy Seshacharyulu, Shiv Ram Krishn, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|April 17, 2020
Odyssey of trefoil factors in cancer: Diagnostic and therapeutic implicationsRahat Jahan, Ashu Shah, Sophia G Kisling, et al.
Carcinogenesis|July 14, 2012
MUC4 potentiates invasion and metastasis of pancreatic cancer cells through stabilization of fibroblast growth factor receptor 1Satyanarayana Rachagani, Muzafar A Macha, Moorthy P Ponnusamy, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|May 20, 2018
Axed MUC4 (MUC4/X) aggravates pancreatic malignant phenotype by activating integrin-β1/FAK/ERK pathwayRahat Jahan, Muzafar A Macha, Satyanarayana Rachagani, et al.
Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology|December 31, 2009
Clinical significance of TC21 overexpression in oral cancerMuzafar A Macha, Ajay Matta, Uma Sriram, et al.
Cancer Letters|August 8, 2013
Guggulsterone decreases proliferation and metastatic behavior of pancreatic cancer cells by modulating JAK/STAT and Src/FAK signalingMuzafar A Macha, Satyanarayana Rachagani, Suprit Gupta, et al.
Molecular Diversity|February 21, 2025
Explainable AI-driven prediction of APE1 inhibitors: enhancing cancer therapy with machine learning models and feature importance analysisAga Basit Iqbal, Tariq Ahmad Masoodi, Ajaz A Bhat, et al.
Pageof 9

Showing results (11-20 of 81) with videos related to

Sort By:
Pageof 9
International Journal of Cancer|January 15, 2009
Cytoplasmic accumulation of activated leukocyte cell adhesion molecule is a predictor of disease progression and reduced survival in oral cancer patientsMeenakshi Sawhney, Ajay Matta, Muzafar A Macha, et al.
Advanced Drug Delivery Reviews|December 3, 2014
Clinical implications of miRNAs in the pathogenesis, diagnosis and therapy of pancreatic cancerSatyanarayana Rachagani, Muzafar A Macha, Nicholas Heimann, et al.
Carcinogenesis|November 27, 2018
Novel therapies hijack the blood-brain barrier to eradicate glioblastoma cancer stem cellsRaghupathy Vengoji, Moorthy P Ponnusamy, Satyanarayana Rachagani, et al.
Current Pharmaceutical Design|February 1, 2014
MicroRNAs (miRNAs) as biomarker(s) for prognosis and diagnosis of gastrointestinal (GI) cancersMuzafar A Macha, Parthasarathy Seshacharyulu, Shiv Ram Krishn, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|April 17, 2020
Odyssey of trefoil factors in cancer: Diagnostic and therapeutic implicationsRahat Jahan, Ashu Shah, Sophia G Kisling, et al.
Carcinogenesis|July 14, 2012
MUC4 potentiates invasion and metastasis of pancreatic cancer cells through stabilization of fibroblast growth factor receptor 1Satyanarayana Rachagani, Muzafar A Macha, Moorthy P Ponnusamy, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|May 20, 2018
Axed MUC4 (MUC4/X) aggravates pancreatic malignant phenotype by activating integrin-β1/FAK/ERK pathwayRahat Jahan, Muzafar A Macha, Satyanarayana Rachagani, et al.
Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology|December 31, 2009
Clinical significance of TC21 overexpression in oral cancerMuzafar A Macha, Ajay Matta, Uma Sriram, et al.
Cancer Letters|August 8, 2013
Guggulsterone decreases proliferation and metastatic behavior of pancreatic cancer cells by modulating JAK/STAT and Src/FAK signalingMuzafar A Macha, Satyanarayana Rachagani, Suprit Gupta, et al.
Molecular Diversity|February 21, 2025
Explainable AI-driven prediction of APE1 inhibitors: enhancing cancer therapy with machine learning models and feature importance analysisAga Basit Iqbal, Tariq Ahmad Masoodi, Ajaz A Bhat, et al.
Pageof 9